Clive M. Michelo
Lusaka, Zambia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.
Journal: The Lancet. Microbe
Published: March 22, 2024
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV.
Journal: Frontiers in immunology
Published: September 08, 2023
Cohort-Specific Peptide Reagents Broaden Depth and Breadth Estimates of the CD8 T Cell Response to HIV-1 Gag Potential T Cell Epitopes.
Journal: Vaccines
Published: January 20, 2023
Use of laboratory-developed assays in global HIV-1 treatment-monitoring and research.
Journal: Scientific reports
Published: July 25, 2022
Sub-Saharan Africa preparedness and response to the COVID-19 pandemic: A perspective of early career African scientists.
Journal: Wellcome open research
Published: September 23, 2020
Comprehensive epitope mapping using polyclonally expanded human CD8 T cells and a two-step ELISpot assay for testing large peptide libraries.
Journal: Journal of immunological methods
Published: June 05, 2020
Protective HLA alleles are associated with reduced LPS levels in acute HIV infection with implications for immune activation and pathogenesis.
Journal: PLoS pathogens
Published: March 22, 2019
HIV transmission in discordant couples in Africa in the context of antiretroviral therapy availability.
Journal: AIDS (London, England)
Published: May 16, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026